Some potential biomarkers, e.g. SOX11 and miR-204 which could cause cell proliferation but inhibit invasion or metastasis could be potential therapeutic targets for malignant pancreatic tumors to lighten their malignant degree. Here, SOX11 is linked to pancreatic neoplasm.